Skip to main content

Table 1 Interview responses part 1

From: Case studies for implementing MCDA for tender and purchasing decisions in hospitals in Indonesia and Thailand

  Thailand hospital tender (n = 4) Indonesia hospital drug purchasing (n = 4)
Rationale for using MCDA Improve quality at reasonable cost
Achieve transparency with agreed criteria
Consistency across hospitals
Listing only the best (most effective and affordable) alternatives
Rational selection process
Decisions meet hospital needs
Opportunities: expected differences due to MCDA (number of mentions) Better patient health [3]
Transparency [2]
Better accuracy/consistency in scoring [2]
Better acceptance of purchasing decision by HCP and patients [2]
Quality improvement [1]
More fairness in tender [1]
Change in hospital purchasing practices [1]
Better product performance [1]
Awareness [1]
Better guidance of companies what type of products are expected [1]
Better access for high-quality products [1]
Quality of products [4]
Affordability [2]
More objective/rational decision [2]
Transparency in tender or formulary selection [2]
Fairness in Off-Patent-Pharmaceutical market [1]
Better decisions on the formulary [1]
Better (monitoring of) availability [1]
More (objective) consideration of value-added services [1]
  1. Summary of interview responses relating to the rationale for using MCDA in the respective decision process and the expected improvements (differences), which could be achieved